Nitinotes is a privately-held medical device company based in caesarea Israel. Its flagship product is the endozipâ„¢, a novel gastroscopic solution for safer, simpler GI suturing. Backed by preclinical success and prominent KOLs, Nitinotes's gastric restriction proceedure provides an effective, minimally-invasive solution to class 1 and 2 obesity patients, for the majority of whom gold-standard bariatric surgery is uncovered and/or inadvisable.